The Pros and Cons of Ozempic: A Comprehensive Review

Researchers are exploring the development of a daily pill as a potential weight loss medication in the GLP-1 agonist class, which includes drugs like Ozempic and Wegovy. These injectable medications have shown promising results in helping people lose weight, with some achieving an average weight loss of 12%. Clinical trials have revealed that a semaglutide pill resulted in an average weight loss of 15% over a 68-week period, while other GLP-1 pills from Eli Lilly and Pfizer have also shown positive outcomes. The introduction of a weight loss pill could provide more options for patients who are unable to do injections and improve access to medications for overweight and obese individuals.